Table 1: Patient Characteristics.
BMI = Body mass index, FIGO = International Federation of Gynecology and Obstetrics.
†FIGO Staging not done on Melanoma (n = 10), or Neuro-endocrine tumours (n = 2).
| Patient Characteristic | Study Group (n = 333) |
| Age, years (Range 20 – 96) |
| Mean | 67 |
| Median | 71 |
| Smoking status |
| Current | 77 (23.1%) |
| Former | 45 (13.5%) |
| Never | 211 (63.2%) |
| BMI (Range 14.6 – 54.7) |
| < 20 | 13 (3.9%) |
| 20 - < 30 | 230 (69.1%) |
| 30 – 35 | 66 (19.8%) |
| > 35 | 24 (7.2%) |
| Diabetic |
| Insulin dependent | 16 (4.8%) |
| Non-Insulin dependent | 31 (9.3%) |
| Histopathological sub-type |
| Squamous cell carcinoma | 302 (90.7%) |
| Melanoma | 10 (3%) |
| Adenocarcinoma | 8 (2.4%) |
| Sarcoma | 6 (1.8%) |
| Other | 7 (2%) |
| FIGO Stage 2009† |
| 1B | 182 (54.6%) |
| 11 | 12 (3.6%) |
| 111A (1) | 39 (11.7%) |
| 111A (11) | 15 (4.5%) |
| 111B (1) | 5 (1.5%) |
| 111B (11) | 11 (3.3%) |
| 111C | 42 (12.6%) |
| 1VA (1) | 3 (0.9%) |
| 1VA (11) | 7 (2.1%) |
| 1VB | 5 (1.5%) |
| Groin Radiotherapy |
| Neoadjuvant | 12 (3.6%) |
| Adjuvant | 69 (20.7%) |